Last Updated: April 12, 2021
- Horizon Therapeutics had Tepezza on back order because the manufacturing facility is being used to make COVID-19 vaccine. Additional information can be found at https://www.horizontherapeutics.com/media-center/horizon-resources/statement-on-short-term-tepezza-supply-disruption or https://www.hzndocs.com/tepezza-short-term-supply-disruption-FAQ.pdf.
- Tepezza intravenous lyophilized powder for injection, Horizon Therapeutics, 500 mg, single dose vial, 1 count, NDC 75987-0130-15
Estimated Resupply Dates
- Horizon Therapeutics has Tepezza available.
Updated April 12, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 10, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.